Clinical Trial Update: Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD) [Phase 2]

View source ↗

Summary

Phase 2 trial of micafungin as antifungal prophylaxis after cord blood allogeneic stem cell transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• Mycamine (Micafungin)

Snippet

Sponsor: Nantes University Hospital | Conditions: Invasive Fungal Infection | Phase 2 | Status: COMPLETED